'Fat gene' discovery leads to hope for treating obesity
Source: Agencies |
July 16, 2013, Tuesday
|
Print Edition
Print Edition
SCIENTISTS have unraveled how a gene long associated with obesity makes people fat by triggering increased hunger, opening up potential new ways to fight a growing global health problem.
A common variation in the FTO gene affects one in six of the population, making them 70 percent more likely to become obese - but until now experts did not know why.
Using a series of tests, a British-led research team said they had found people with the variation not only had higher levels of the "hunger hormone" ghrelin in their blood but also increased sensitivity to the chemical in their brains.
"It's a double hit," said Rachel Batterham from University College London, who led the study, which was published in the Journal of Clinical Investigation yesterday.
The discovery follows studies of blood samples from people after meals, combined with magnetic resonance imaging of volunteers' brains and cell-based studies looking at ghrelin production at a molecular level.
Batterham said the work provided new insights and possible new leads for treatment, since some experimental drugs are known to suppress ghrelin and could be particularly effective if targeted at patients with the obesity-risk variant of the gene.
Previous research showed ghrelin can be reduced by eating a high-protein diet.
Steve Bloom of Imperial College London, who was not involved in the study, said the FTO gene only explained a small part of the obesity epidemic but the latest discovery was "an important step forward" in unraveling the various factors involved.
The prevalence of obesity is increasing worldwide at an alarming rate and both developed and developing countries are affected. Obesity is a major risk factor for diabetes, heart disease and certain cancers.
At least 2.8 million adults die each year as a result of being overweight or obese.
A common variation in the FTO gene affects one in six of the population, making them 70 percent more likely to become obese - but until now experts did not know why.
Using a series of tests, a British-led research team said they had found people with the variation not only had higher levels of the "hunger hormone" ghrelin in their blood but also increased sensitivity to the chemical in their brains.
"It's a double hit," said Rachel Batterham from University College London, who led the study, which was published in the Journal of Clinical Investigation yesterday.
The discovery follows studies of blood samples from people after meals, combined with magnetic resonance imaging of volunteers' brains and cell-based studies looking at ghrelin production at a molecular level.
Batterham said the work provided new insights and possible new leads for treatment, since some experimental drugs are known to suppress ghrelin and could be particularly effective if targeted at patients with the obesity-risk variant of the gene.
Previous research showed ghrelin can be reduced by eating a high-protein diet.
Steve Bloom of Imperial College London, who was not involved in the study, said the FTO gene only explained a small part of the obesity epidemic but the latest discovery was "an important step forward" in unraveling the various factors involved.
The prevalence of obesity is increasing worldwide at an alarming rate and both developed and developing countries are affected. Obesity is a major risk factor for diabetes, heart disease and certain cancers.
At least 2.8 million adults die each year as a result of being overweight or obese.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
